Orchid exists to save men's lives from testicular, prostate and penile cancers
through pioneering research and promoting awareness
Orchid funds clinical and scientific medical research to ensure a better quality of life for all men affected by male specific cancers. We aim to ensure the best treatments are available to all men, by making the results of our research widely accessible to enable treatment with minimum side effects. Our research programme has identified new ways to treat male cancers and improved our understanding of how these cancers behave. Since Orchid was founded in 1996, we have invested over £6 million in exceptional projects that are reviewed and approved by an eminent independent Scientific Advisory Board.